uk 34787 has been researched along with 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid in 1 studies
Studies (uk 34787) | Trials (uk 34787) | Recent Studies (post-2010) (uk 34787) | Studies (2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid) | Trials (2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid) | Recent Studies (post-2010) (2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid) |
---|---|---|---|---|---|
7 | 0 | 0 | 122 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blockmans, D; Deckmyn, H; Gresele, P; Vermylen, J | 1 |
1 other study(ies) available for uk 34787 and 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid
Article | Year |
---|---|
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
Topics: Adenylyl Cyclases; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Dinoprostone; Eicosanoic Acids; Enzyme Activation; Female; Humans; Imidazoles; Indoles; Male; Methacrylates; Middle Aged; Platelet Aggregation; Prostaglandins E; Pyridines; Thromboxane-A Synthase | 1988 |